The idea of Modern Medtech Park in Delhi germinates

Delhi’s Industry Minister sounded amenable, signals west Delhi as site

New Delhi: Modern Medical Device Manufacturing Cluster in Delhi may become a reality in foreseeable future. The Surgical Manufacturers & Traders Association (SMTA) gets a very positive nod from Industries Minister Sardar Manjinder Singh Sirsa in an event in Delhi. This will be godsend for manufacturing units in Lal Dora and unorganized slums.

Rajiv Nath, one of greatest champions of Make in India in Medical Device Domain, feels modern medtech park in Delhi is the need of the hour. Managing Director of Hindustan Syringes (HMD), a scintillating success story in syringe making, Mr Nath calling HMD a proud member of SMTA, is very optimistic about its prospect because of late he finds Union government very proactively promoting Make in India. Mr Nath, also forum coordinator of Association of Indian Medical Device Industry (AiMeD) not long ago, was prolific in praise for the government for ensuring level playing field for domestic medical device manufactures vis a vis foreign manufacturers.

Rajiv Nath in talk with Medicare News said, “Existing Delhi based medical devices units making surgical instruments, stethoscopes, or rehabilitation orthopaedic aids etc need to relocate n expand n b compliant to evolving regulatory requirements under MDR n pollution n factory Act norms for which a modern medical device cluster supporting infrastructure is needed as existence in Lal Dora n unorganised slums is threatened.”

Mr Nath further said, “The Industry Minister was kindly very empathetic to the needs n offered promptly pragmatic solutions- hopefully the idea of a Medtech Park in west Delhi will germinate into a tangible development in very near future to enable MakeinIndia n MakeinDelhi to stem the tide of UnmakeinDelhi n entrepreneurs being pushed out of Delhi”

Related Posts

Pharma companies in a flux over Trump’s 200% tariff move on generics

India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

CDSCO declares 159 drug samples as NSQs in June

CDSCO declares 159 drug samples as NSQs in June